Rakesh K P, Vivek H K, Manukumar H M, Shantharam C S, Bukhari S N A, Qin Hua-Li, Sridhara M B
Department of Pharmaceutical Engineering, School of Chemistry, Chemical Engineering and Life Science, Wuhan University of Technology 205 Luoshi Road Wuhan 430073 PR China
Analytical Research and Development, Syngene International Ltd Biocon Park, Bommasandra Industrial Estate Bangaluru-560099 Karnataka India.
RSC Adv. 2018 Jan 31;8(10):5473-5483. doi: 10.1039/c7ra13661g. eCollection 2018 Jan 29.
Gram-negative members of the ESCAPE family are more difficult to treat, due to the presence of an additional barrier in the form of a lipopolysaccharide layer and the efficiency of efflux pumps to pump out the drugs from the cytoplasm. The development of alternative therapeutic strategies to tackle ESCAPE Gram-negative members is of extreme necessity to provide a solution to the cause of life-threatening infections. The present investigations demonstrated that compounds 17, 20, 25 and 26 possessing the presence of electron donating (OH and OCH) groups on the phenyl rings are highly potent; whereas compounds 9, 10, 15, 16, 18, 33 and 36 showed moderate activity against Gram-negative bacteria. An excellent dose-dependent antibacterial activity was established compared to that of the standard antibiotic ampicillin. Significant anti-biofilm properties were measured quantitatively, showing optical density (O.D) values of 0.51 ± 015, 0.63 ± 0.20, 0.38 ± 0.07 and 0.62 ± 0.11 at 492 nm and the leakage of cellular components by the compounds, such as 17, 20, 25 and 26, increased the O.D. of respective treated samples compared to the control. In addition, the implication of experimental results is discussed in the light of the lack of survivability of planktonic bacteria and biofilm destruction . These results revealed the great significance of the development of a new generation of synthetic materials with greater efficacy in anti-biofilm properties by targeting to lock the bio-film associated protein Bap in Gram-negative bacteria.
ESCAPE家族中的革兰氏阴性菌更难治疗,这是因为存在一层脂多糖形式的额外屏障,以及外排泵将药物从细胞质中泵出的效率。开发替代治疗策略来对付ESCAPE家族中的革兰氏阴性菌极为必要,以便为危及生命的感染病因提供解决方案。目前的研究表明,在苯环上带有供电子基团(OH和OCH)的化合物17、20、25和26具有很高的效力;而化合物9、10、15、16、18、33和36对革兰氏阴性菌表现出中等活性。与标准抗生素氨苄青霉素相比,建立了优异的剂量依赖性抗菌活性。定量测定了显著的抗生物膜特性,在492nm处的光密度(O.D)值分别为0.51±0.15、0.63±0.20、0.38±0.07和0.62±0.11,并且化合物17、20、25和26等导致细胞成分泄漏,与对照相比增加了各自处理样品的O.D。此外,根据浮游细菌的生存能力缺乏和生物膜破坏情况讨论了实验结果的意义。这些结果揭示了开发新一代合成材料的重大意义,该材料通过靶向锁定革兰氏阴性菌中与生物膜相关的蛋白质Bap而具有更强的抗生物膜特性。